Ignite Creation Date:
2024-05-05 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00480220
Status:
COMPLETED
Last Update Posted:
2015-08-19
First Post:
2007-05-29
Brief Title:
Specific Care and Assistance Plan for Alzheimers Disease
Sponsor:
University Hospital Toulouse
Organization:
University Hospital Toulouse
Study Overview
Official Title:
Specific Care and Assistance Plan for Alzheimers Disease Impact Study on Disease Progression and Management Modalities
Status:
COMPLETED
Status Verified Date:
2015-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PLASA
Brief Summary:
The main objective of this work is to assess the feasibility and efficacy of a specific Care and Assistance Plan for Alzheimers disease PLASA The main outcome measure selected is incapacity in carrying out the basic activities of daily living evaluated by the ADCS-ADL scale
The PLASA was developed by a working group appointed by the Direction Générale de la Santé as part of the government programme of action on Alzheimers disease October 2001 Ministère de lEmploi et de la Solidarité
The PLASA was developed by a working group appointed by the Direction Générale de la Santé as part of the government programme of action on Alzheimers disease October 2001 Ministère de lEmploi et de la Solidarité
Detailed Description:
It is estimated that at the present time about 50 of dependence in the elderly is related to dementias Alzheimers disease is the most common of these and there are 100 000 new cases in France every year Girard Report Very often once the diagnosis has been established these persons do not receive regular codified follow-up whereas Alzheimers disease is a chronic disease which progresses over several years and leads to a variety of complications which must be identified and managed
The main objective of this work is to assess the feasibility and efficacy of a specific Care and Assistance Plan for Alzheimers disease PLASA The main outcome measure selected is incapacity in carrying out the basic activities of daily living evaluated by the ADCS-ADL scale
The PLASA was developed by a working group appointed by the Direction Générale de la Santé as part of the government programme of action on Alzheimers disease October 2001 Ministère de lEmploi et de la Solidarité
Methods The multicentre prospective study will be randomised within each centre Study population 1200 patients will be recruited in 20 French university hospitals and 40 general hospitals
Inclusion criteria Patients presenting mild to moderate Alzheimers disease diagnosed by the NINCDS-ADRDA criteria MMSE between 12 and 26 living at home and with an identified principal caregiver
Randomisation and patient follow-up After randomisation within each centre specialised department of the university or general hospital half of the patients will be managed according to the PLASA group A The other patients will receive the usual management of the centres group B
The PLASA includes detailed evaluation of the patients cognitive and non-cognitive function regular and standardised follow-up management of complications and the setting up of assistance and support services according to common guidelines As part of the PLASA patients will be systematically seen in consultation every six months
Data collection In group A data will be collected during six-monthly consultations for the duration of the study T0 T6 T12 T18 T24 In group B data will be collected during consultations at T0 T12 and T24 The coordinating centre Toulouse will contact every 6 months T6 T12 T18 T24 by post or by telephone the principal caregiver for collection of intermediate data in both groups These data include evaluation of activities of daily living ADCS-ADL utilization of support and care services RUD as well as subjective assessment of disease severity ADCS-CGIC The patients quality of life will also be evaluated in both groups at T0 T12 and T24
Statistical analysis 1200 subjects are needed to reveal a 30 decrease in incapacities in activities of daily living in the group of patients followed according to the PLASA
Bivariate analysis will be carried out using the standard tests for this type of study chi-squared test and Students t test The efficacy of the PLASA will be assessed by multivariate analysis taking potential confounders into account
Expected results This project should contribute to better long-term management of patients with Alzheimers disease and should reduce the burden on families
The main objective of this work is to assess the feasibility and efficacy of a specific Care and Assistance Plan for Alzheimers disease PLASA The main outcome measure selected is incapacity in carrying out the basic activities of daily living evaluated by the ADCS-ADL scale
The PLASA was developed by a working group appointed by the Direction Générale de la Santé as part of the government programme of action on Alzheimers disease October 2001 Ministère de lEmploi et de la Solidarité
Methods The multicentre prospective study will be randomised within each centre Study population 1200 patients will be recruited in 20 French university hospitals and 40 general hospitals
Inclusion criteria Patients presenting mild to moderate Alzheimers disease diagnosed by the NINCDS-ADRDA criteria MMSE between 12 and 26 living at home and with an identified principal caregiver
Randomisation and patient follow-up After randomisation within each centre specialised department of the university or general hospital half of the patients will be managed according to the PLASA group A The other patients will receive the usual management of the centres group B
The PLASA includes detailed evaluation of the patients cognitive and non-cognitive function regular and standardised follow-up management of complications and the setting up of assistance and support services according to common guidelines As part of the PLASA patients will be systematically seen in consultation every six months
Data collection In group A data will be collected during six-monthly consultations for the duration of the study T0 T6 T12 T18 T24 In group B data will be collected during consultations at T0 T12 and T24 The coordinating centre Toulouse will contact every 6 months T6 T12 T18 T24 by post or by telephone the principal caregiver for collection of intermediate data in both groups These data include evaluation of activities of daily living ADCS-ADL utilization of support and care services RUD as well as subjective assessment of disease severity ADCS-CGIC The patients quality of life will also be evaluated in both groups at T0 T12 and T24
Statistical analysis 1200 subjects are needed to reveal a 30 decrease in incapacities in activities of daily living in the group of patients followed according to the PLASA
Bivariate analysis will be carried out using the standard tests for this type of study chi-squared test and Students t test The efficacy of the PLASA will be assessed by multivariate analysis taking potential confounders into account
Expected results This project should contribute to better long-term management of patients with Alzheimers disease and should reduce the burden on families
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| PHRC | OTHER_GRANT | 2001 and 2006 | None |